Rush University Medical Center

Early Predictor of Severe Respiratory Failure in Patients With COVID-19 Identified

Findings published in Critical Care suggest that high plasma levels of the protein suPAR are associated with worse outcomes

Newswise — A very high level of a protein known as suPAR in the blood of patients with COVID-19 may be a predictor of severe respiratory failure, according to new research published in the Journal of Critical Care on April 30. The findings by researchers at Rush University Medical Center and other institutions suggest suPAR could be a potential predictor for which patients with COVID-19 will need to be put on ventilators to help them breathe.

“This is the first report in the world to show that suPAR is elevated in COVID-19 and is predictive. Since suPAR is a reactant of the innate immune system, it’s an indicator of disease severity,” said Jochen Reiser, MD, PhD, the Ralph C. Brown, MD, Professor of Internal Medicine, chairperson of the Department of Internal Medicine at Rush.

“These results show that the higher the plasma suPAR level, the worse the outcome will be in the lungs of these patients,” said Reiser, who is co-correspondent author of the study. “The higher the suPAR level, the shorter the time before patients needed intubation.”

Reiser’s research team tested suPAR levels in 15 Rush patients when they were admitted or tested for COVID-19. The University of Athens Medical School measured 57 patients for suPAR and followed them in their clinical course. Time to intubation was followed and found to be shorter in patients with a higher plasma suPAR.

“There is a body of literature that suPAR is associated with poor outcomes from acute respiratory distress syndrome (a condition in many patients with severe COVID-19) and poor lung functioning in critically ill patients,” Reiser said.

Reiser also mentions that the link between suPAR and respiratory failure suggests a way to help manage patients with COVID-19.

“If we measure suPAR as part of diagnosing COVID-19, we may know whom to watch more and whom to send home,” he said. “Plasma suPAR levels give us a window into the course of the disease, allowing for an improved monitoring and applying new and supportive treatments early.” 

The findings of the present research raise additional new questions about a role for suPAR in COVID-19-associated organ dysfunction.

Soluble urokinase plasminogen activator receptor, aka suPAR, is produced in the endobronchial tree in the lungs and by immune cells in the bone marrow and repeatedly has been shown to harm kidneys. In two publications in The New England Journal of Medicine, Reiser’s research showed that chronically elevated blood levels are linked to development of chronic kidney disease, yet a high plasma suPAR also increases the risk for acute kidney injury – a sudden decline in kidney function that can be a severe side effect of general medical procedures.

Reportedly, an increasing number of patients with severe COVID-19 also develop kidney problems, which is leading researchers to investigate the connection between COVID-19, suPAR and kidney disease.

“Our research on suPAR and COVID-19 associated lung injury is based on a small sample size, and we will need more data, but the findings support a concept that suPAR is harmful in COVID-19. It may therefore play a prognostic and a causal role in COVID-19 associated kidney disease, Reiser said.”

Funding for this work was provided by unrestricted educational grants by the Hellenic Institute for the Study of Sepsis. Funds were also provided by Rush University Medical Center.

 




Filters close

Showing results

2130 of 2911
access_time Embargo lifts in 2 days
Embargo will expire: 18-Aug-2020 11:00 AM EDT Released to reporters: 13-Aug-2020 8:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded sharp-jump-in-stillbirths-during-covid-lockdown
VIDEO
Released: 12-Aug-2020 9:05 PM EDT
Sharp jump in stillbirths during COVID lockdown
University of South Australia

A four-fold increase in stillbirths in a large UK maternity hospital during the COVID-19 pandemic might also be replicated in Australia and elsewhere due to guidelines which have discouraged face-to-face antenatal visits in recent months.

access_time Embargo lifts in 2 days
Embargo will expire: 14-Aug-2020 2:00 PM EDT Released to reporters: 12-Aug-2020 7:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Aug-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective
Released: 12-Aug-2020 6:30 PM EDT
Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective
Houston Methodist

A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective. The results, published in The American Journal of Pathology, represent one of the first peer-reviewed publications in the country assessing efficacy of convalescent plasma and offer valuable scientific evidence that transfusing critically ill COVID-19 patients with high antibody plasma early in their illness reduced the mortality rate.

Newswise: When you’re smiling, the whole world really does smile with you
11-Aug-2020 11:00 PM EDT
When you’re smiling, the whole world really does smile with you
University of South Australia

From Sinatra to Katy Perry, celebrities have long sung about the power of a smile – how it picks you up, changes your outlook, and generally makes you feel better. But is it all smoke and mirrors, or is there a scientific backing to the claim? Groundbreaking research from the University of South Australia confirms that the act of smiling can trick your mind into being more positive, simply by moving your facial muscles.

Released: 12-Aug-2020 3:50 PM EDT
MTSU, Texas State professors posit pandemic offers 'largest criminological experiment in history'
Middle Tennessee State University

In a research paper published in the American Journal of Criminal Justice, Ben Stickle, an associate professor of criminal justice administration, posits that the novel coronavirus tragedy presents a unique opportunity for a “randomized control trial.” The paper is co-authored by Stickle and Marcus Felson of Texas State University in San Marcos, Texas.

Newswise:Video Embedded clearing-confusion-on-asymptomatic-spread
VIDEO
Released: 12-Aug-2020 3:30 PM EDT
Clearing confusion on asymptomatic spread
UW Medicine

Confusion abounds about the difference between asymptomatic and pre-symptomatic infections when it comes to the pandemic coronavirus. Dr. John Lynch, medical director of infection prevention and control at Harborview, explains what it means.

Released: 12-Aug-2020 2:35 PM EDT
Survey Results Detail Signs of Improving Conditions for CRNAs
American Association of Nurse Anesthetists (AANA)

The American Association of Nurse Anesthetists (AANA) discovered in a new survey that employment opportunities for Certified Registered Nurse Anesthetists (CRNAs) during the COVID-19 public health crisis is improving.

Released: 12-Aug-2020 2:05 PM EDT
Combating child weight gain during COVID-19
University of Texas Health Science Center at Houston

The infamous “Quarantine 15,” a reference to packing on the pounds during the pandemic, is affecting even the youngest of Americans, according to UT Physicians pediatricians, who are seeing the evidence in front of them via telemedicine appointments.

Newswise:Video Embedded jhu-robotic-system-remotely-controls-ventilators-in-covid-19-patient-rooms
VIDEO
Released: 12-Aug-2020 1:10 PM EDT
JHU Robotic System Remotely Controls Ventilators In COVID-19 Patient Rooms
Johns Hopkins University

A new robotic system allows medical staff to remotely operate ventilators and other bedside machines from outside intensive care rooms of patients suffering from infectious diseases.


Showing results

2130 of 2911

close
3.07775